Eligi
Med
Base de datos
Seguridad
Sobre EligiMed
Contacto
Contáctenos
Ensayos Clínicos | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Completado
Fase 2
ClinicalTrials.gov
A Phase II Multicenter, Randomized, Double-blind, Placebo-controlled, Dose-ranging, Parallel Group Study of the Safety and Efficacy of the Oral NeuroKinin-1 Receptor Antagonist, GW679769 in Combination With Ondansetron Hydrochloride and Dexamethasone for the Prevention of Chemotherapy-Induced Nausea
INTERVENTIONAL
Inicio: 1 de dic de 2004
ID: NCT00104403
Completado
Fase 2
ClinicalTrials.gov
A Double Blind, Randomized, Placebo Controlled, Multicenter, Dose Finding Study of Oral AEB071 Assessing Psoriasis Area and Severity Index (PASI) Response and a Function of Dose and Treatment Duration (Primary Outcome) in Patients With Plaque Psoriasis
INTERVENTIONAL
Inicio: 1 de abr de 2009
ID: NCT00885196
Completado
Fase 4
ClinicalTrials.gov
Clinical Metabolic and Endocrine Parameters in Response to Metformin and Lifestyle Intervention in Women With Polycystic Ovary Syndrome: A Phase 4 Randomized, Double- Blind and Placebo Control Trial
INTERVENTIONAL
Inicio: 1 de ene de 2003
ID: NCT00679679
Completado
Fase 3
ClinicalTrials.gov
A Phase 3 Study With Asunaprevir and Daclatasvir (DUAL) for Null or Partial Responders to Peginterferon Alfa and Ribavirin (P/R), Intolerant or Ineligible to P/R Subjects and Treatment-Naive Subjects With Chronic Hepatitis C Genotype 1b Infection
INTERVENTIONAL
Inicio: 1 de may de 2012
ID: NCT01581203
Completado
ClinicalTrials.gov
Frontline Approach for BRCA Testing in OC Treatment naïve Population. A LATIN AMERICA Epidemiologic Study
OBSERVATIONAL
Inicio: 27 de dic de 2016
ID: NCT02984423
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Efficacy and Safety Study of Toremifene Citrate for the Prevention of Prostate Cancer in Men With High Grade Prostatic Intraepithelial Neoplasia (PIN)
INTERVENTIONAL
Inicio: 1 de ene de 2005
ID: NCT00106691
Completado
Fase 3
ClinicalTrials.gov
A Randomised, Double Blind, Double Dummy, Parallel Group, Active Controlled Trial to Evaluate the Antiviral Efficacy of 400 mg QD neVirapine Extended Release Formulation in Comparison to 200 mg BID neVirapinE Immediate Release in Combination With Truvada® in Antiretroviral Therapy naïve HIV-1 Infected Patients (VERxVE)
INTERVENTIONAL
Inicio: 1 de nov de 2007
ID: NCT00561925
Completado
ClinicalTrials.gov
Analysis of Efficacy of the Mental Training Tech 245: a Novel Method of Cognitive Stimulation Based on Brain Neuroplastic Ability
INTERVENTIONAL
Inicio: 2 de mar de 2023
ID: NCT06549517
Completado
Fase 3
ClinicalTrials.gov
Randomized, Double-Blind, Placebo-Controlled Study of Efficacy and Safety of Donepezil Hydrochloride in Preadolescent and Adolescent Children With Attention Impairment Following Cancer Treatment
INTERVENTIONAL
Inicio: 2 de jul de 2008
ID: NCT00688376
Desconocido
ClinicalTrials.gov
How Does the EUS-guided Through-the-needle Microforceps Biopsy Improve Diagnosis of Pancreatic Cystic Lesions: A Multicenter Prospective Study
OBSERVATIONAL
Inicio: 22 de oct de 2019
ID: NCT04140435
Completado
Fase 4
ClinicalTrials.gov
A 54 Week, Randomized, Double-blind, Parallel-group, Multicenter Study Evaluating the Long-term Gastrointestinal (GI) Safety and Tolerability of Aliskiren (300 mg) Compared to Ramipril (10 mg) in Patients With Essential Hypertension
INTERVENTIONAL
Inicio: 1 de feb de 2008
ID: NCT00631917
Completado
Fase 3
ClinicalTrials.gov
An Open Label, Multi-center, Phase 3 Study With Corresponding Blinded Image Reading to Determine the Efficacy and Safety of a Single Intravenous Injection of 0.1 mmol/kg Body Weight of Gadobutrol 1.0 Molar (Gadovist®) in Patients With Newly Diagnosed Breast Cancer Referred for Contrast-enhanced Breast MRI
INTERVENTIONAL
Inicio: 1 de feb de 2010
ID: NCT01067976
Terminado
Fase 2
ClinicalTrials.gov
A Phase 2, Randomized, Double-Blind, Placebo Controlled, Parallel Group Study (TRANSFORM) to Evaluate the Efficacy and Safety of GSK3915393 in Participants With Idiopathic Pulmonary Fibrosis (IPF)
INTERVENTIONAL
Inicio: 4 de abr de 2024
ID: NCT06317285
Completado
Fase 3
ClinicalTrials.gov
A Randomized, 3 Arm, Multicenter, Phase III Study to Evaluate the Efficacy and the Safety of T-DM1 Combined With Pertuzumab or T-DM1 Combined With Pertuzumab-Placebo (Blinded for Pertuzumab), Versus the Combination of Trastuzumab Plus Taxane, as First Line Treatment in HER2 Positive Progressive or Recurrent Locally Advanced or Metastatic Breast Cancer
INTERVENTIONAL
Inicio: 31 de jul de 2010
ID: NCT01120184
Completado
Fase 2
ClinicalTrials.gov
A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Determine the Efficacy, Safety, and Tolerability of AMG 785 in Adults With a Fresh Unilateral Hip Fracture, Status Post Surgical Fixation
INTERVENTIONAL
Inicio: 20 de jun de 2010
ID: NCT01081678
Completado
Fase 3
ClinicalTrials.gov
A Phase 3, Multi-center, Open-label, Randomized Study of Oral ABL001 Versus Bosutinib in Patients With Chronic Myelogenous Leukemia in Chronic Phase (CML-CP), Previously Treated With 2 or More Tyrosine Kinase Inhibitors
INTERVENTIONAL
Inicio: 26 de oct de 2017
ID: NCT03106779
Completado
ClinicalTrials.gov
Post Marketing Clinical Evaluation Assessing the Visual Performance of Hanita Lenses "Intensity SL" Intraocular Lens
OBSERVATIONAL
Inicio: 1 de mar de 2023
ID: NCT06075459
Completado
Fase 4
ClinicalTrials.gov
PHASE IV, MULTICENTRIC, DOUBLE-BLIND, RANDOMIZED, CONTROLLED,60 DAYS, PARALLEL GROUPS, SUPERIORITY STUDY, TO COMPARE THE EFFECTIVENESS AND TOXICITY OF BEPOTASTINE 1.5% PF vs. OLOPATADINE 0.2% WITH BAK IN TREATMENT OF ALLERGIC CONJUNCTIVITIS
INTERVENTIONAL
Inicio: 10 de mar de 2021
ID: NCT04776096
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double-Blind Phase 3 Study Of Gemcitabine Plus AG-013736 Versus Gemcitabine Plus Placebo For The First-Line Treatment Of Patients With Locally Advanced, Unresectable Or Metastatic Pancreatic Cancer.
INTERVENTIONAL
Inicio: 1 de jul de 2007
ID: NCT00471146
Completado
Fase 3
ClinicalTrials.gov
Efficacy and Safety of Oral Semaglutide Using a Flexible Dose Adjustment Based on Clinical Evaluation Versus Sitagliptin in Subjects With Type 2 Diabetes Mellitus
INTERVENTIONAL
Inicio: 20 de sept de 2016
ID: NCT02849080
Anterior
1
...
411
412
413
...
434
Siguiente
Filtros